Status:
UNKNOWN
Evaluating a Preventive Heart Health Programme for Women at Midlife
Lead Sponsor:
Alexandra Hospital
Collaborating Sponsors:
National University Hospital, Singapore
Conditions:
Cardiovascular Disease
Menopause
Eligibility:
FEMALE
45-65 years
Brief Summary
This study examines the factors that limit or support the implementation of a pilot heart health program for perimenopausal women. The investigators evaluate the effectiveness of this program in raisi...
Detailed Description
Cardiovascular disease (CVD) is the leading cause of mortality among women. Heart-related conditions are responsible for the death of one out of every three women. In Singapore, CVD in women causes mo...
Eligibility Criteria
Inclusion
- Women aged 45-65 years at risk for cardiovascular disease or with pre-existing cardiovascular disease.
- English speaking
Exclusion
- Pregnant women
- Unable to provide informed consent
- Women out of the menopause transition phase of 45-65 years of age.
Key Trial Info
Start Date :
June 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05967000
Start Date
June 1 2023
End Date
December 31 2024
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandra Hospital
Singapore, Singapore, 159964